Arcutis Biotherapeutics, Inc. (ARQT)
26.91
-0.26
(-0.96%)
USD |
NASDAQ |
Nov 20, 10:46
Arcutis Biotherapeutics Cash from Operations (Quarterly) : 18.90M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 18.90M |
| June 30, 2026 | 12.64M |
| March 31, 2026 | 2.239M |
| December 31, 2025 | 26.18M |
| September 30, 2025 | -1.754M |
| June 30, 2025 | 0.324M |
| March 31, 2025 | -30.38M |
| December 31, 2024 | -0.748M |
| September 30, 2024 | -34.69M |
| June 30, 2024 | -45.12M |
| March 31, 2024 | -31.60M |
| December 31, 2023 | -56.24M |
| September 30, 2023 | -43.98M |
| June 30, 2023 | -66.48M |
| March 31, 2023 | -80.34M |
| December 31, 2022 | -71.06M |
| Date | Value |
|---|---|
| September 30, 2022 | -67.70M |
| June 30, 2022 | -61.98M |
| March 31, 2022 | -56.98M |
| December 31, 2021 | -51.71M |
| September 30, 2021 | -40.88M |
| June 30, 2021 | -35.83M |
| March 31, 2021 | -46.20M |
| December 31, 2020 | -32.10M |
| September 30, 2020 | -34.16M |
| June 30, 2020 | -25.76M |
| March 31, 2020 | -21.01M |
| December 31, 2019 | -18.09M |
| September 30, 2019 | -10.92M |
| June 30, 2019 | -8.154M |
| March 31, 2019 | -7.074M |
| December 31, 2018 | -5.838M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 11.50M |
| ADMA Biologics, Inc. | 17.37M |
| Alnylam Pharmaceuticals, Inc. | 340.98M |
| Anika Therapeutics, Inc. | 8.377M |
| Savara, Inc. | -42.46M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -22.08M |
| Cash from Financing (Quarterly) | 2.453M |
| Free Cash Flow | 59.71M |
| Free Cash Flow Per Share (Quarterly) | 0.1374 |
| Free Cash Flow to Equity (Quarterly) | 9.118M |
| Free Cash Flow to Firm (Quarterly) | 21.70M |
| Free Cash Flow Yield | 1.76% |